In non-steatotic livers undergoing LT and BD, we found that if IL-6 is inhibited (BD+anti-IL-6+LT), hepatic levels of IL-1β are increased only in non-steatotic livers and liver damage is exacerbated in this type of liver. The gene discussed is IL6; the disease is Behcet disease.